Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 132 Records) |
| Query Trace: Tuberculosis and NAT2[original query] |
|---|
| PBPK Analysis to Study the Impact of Genetic Polymorphism of NAT2 on Drug-Drug Interaction Potential of Isoniazid. Pharmaceutical research 2021 9 38 (9): 1485-1496. Balhara Ankit, Singh Saranj |
| Allelic and genotypic frequencies of NAT2, CYP2E1, and AADAC genes in a cohort of Peruvian tuberculosis patients. Molecular genetics & genomic medicine 2021 9 9 (10): e1764. Levano Kelly S, Jaramillo-Valverde Luis, Tarazona David D, Sanchez Cesar, Capristano Silvia, Vásquez-Loarte Tania, Solari Lely, Mendoza-Ticona Alberto, Soto Alonso, Rojas Christian, Zegarra-Chapoñan Roberto, Guio Heinn |
| A Rapid Pharmacogenomic Assay to Detect NAT2 Polymorphisms and Guide Isoniazid Dosing for Tuberculosis Treatment. American journal of respiratory and critical care medicine 2021 Aug . Verma Renu, Patil Sunita, Zhang Nan, Moreira Flora M F, Vitorio Marize T, Santos Andrea da S, Wallace Ellen, Gnanashanmugam Devasena, Persing David H, Savic Rada M, Croda Julio, Andrews Jason |
| Population Pharmacokinetics and Pharmacodynamics of Isoniazid and its Metabolite Acetylisoniazid in Chinese Population. Frontiers in pharmacology 2022 8 13 932686. Chen Bing, Shi Hao-Qiang, Feng Meihua Rose, Wang Xi-Han, Cao Xiao-Mei, Cai Wei-M |
| Pharmacogenetic testing for NAT2 genotypes in a Tanzanian population across the lifespan to guide future personalized isoniazid dosing. Tuberculosis (Edinburgh, Scotland) 2022 8 136 102246. Masiphephethu Maano V, Sariko Margaretha, Walongo Thomas, Maro Athanasia, Mduma Dorcus, Gratz Jean, Alshaer Mohammad, Peloquin Charles A, Mduma Estomih, Mpagama Stellah G, Thomas Tania, Houpt Eric R, Traore Afsatou, Bessong Pascal, Heysell Scott K, Operario Darwin |
| Influence of N-acetyltransferase 2 (NAT2) genotype/single nucleotide polymorphisms on clearance of isoniazid in tuberculosis patients: a systematic review of population pharmacokinetic models. European journal of clinical pharmacology 2022 7 78 (10): 1535-1553. Thomas Levin, Raju Arun Prasath, Chaithra , M Sonal Sekhar, Varma Muralidhar, Saravu Kavitha, Banerjee Mithu, Sv Chidananda Sanju, Mallayasamy Surulivelrajan, Rao Mahad |
| NAT2 and CYP2E1 polymorphisms and antituberculosis drug-induced hepatotoxicity in Peruvian patients. Molecular genetics & genomic medicine 2022 Jun e1987. Jaramillo-Valverde Luis, Levano Kelly S, Tarazona David D, Capristano Silvia, Zegarra-Chapoñan Roberto, Sanchez Cesar, Yufra-Picardo Velia M, Tarazona-Santos Eduardo, Ugarte-Gil Cesar, Guio Heinn |
| Relevance of gene polymorphisms of NAT2 and NR1I2 to anti-tuberculosis drug-induced hepatotoxicity. Xenobiotica; the fate of foreign compounds in biological systems 2022 6 52 (5): 520-526. Wang Ning, Guo Shaochen, Liu Haiting, Ding Yangming, Yao Rong, Liu Zhongquan, Zhu Hui, Chen Xi, Yang Xinting, Chen Xiaoyou, Lu |
| Clinical and Genetic Risk Factors for Drug-Induced Liver Injury Associated with Anti-Tuberculosis Treatment-A Study from Patients of Portuguese Health Centers. Journal of personalized medicine 2022 May 12 (5): . Cavaco Maria João, Alcobia Celeste, Oliveiros Bárbara, Mesquita Luís Alcides, Carvalho Aurora, Matos Fernando, Carvalho José Miguel, Villar Miguel, Duarte Raquel, Mendes João, Ribeiro Carolina, Cordeiro Carlos Robalo, Regateiro Fernando, Silva Henriqueta Coimb |
| NAT2 polymorphism and clinical factors that increase antituberculosis drug-induced hepatotoxicity. Pharmacogenomics 2022 5 23 (9): 531-541. Mohamed Noor Nur Farhana, Salleh Mohd Zaki, Mohd Zim Mohd Arif, Bakar Zamzurina Abu, Fakhruzzaman Noorizhab Mohd Nur, Zakaria Noor Izyani, Lailanor Muhammad Imran, Teh Lay K |
| Homozygotes NAT2*5B slow acetylators are highly associated with hepatotoxicity induced by anti-tuberculosis drugs. Memorias do Instituto Oswaldo Cruz 2022 117 e210328. El-Jaick Kenia Balbi, Ribeiro-Alves Marcelo, Soares Marcos Vinícius Guimarães, Araujo Gabriela Eduardo França de, Pereira Gabriel Rodrigues Coutinho, Rolla Valeria Cavalcanti, Mesquita Joelma Freire De, De Castro Lia |
| Influence of NAT2 Genotype and Maturation on Isoniazid Exposure in Low-Birth-Weight and Preterm Infants With or Without Human Immunodeficiency Virus (HIV) Exposure. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022 2 75 (6): 1037-1045. Béranger Agathe, Bekker Adrie, Solans Belén P, Cotton Mark F, Mirochnick Mark, Violari Avy, Wang Jiajia, Cababasay Mae, Wiesner Lubbe, Browning Renee, Moye Jack, Capparelli Edmund V, Savic Radojka |
| GSTT1/GSTM1 Genotype and Anti-Tuberculosis Drug-Induced Hepatotoxicity in Peruvian Patients. International journal of molecular sciences 2022 10 23 (19): . Jaramillo-Valverde Luis, Levano Kelly S, Tarazona David D, Vasquez-Dominguez Andres, Toledo-Nauto Anel, Capristano Silvia, Sanchez Cesar, Tarazona-Santos Eduardo, Ugarte-Gil Cesar, Guio Heinn |
| N-acetyltransferase 2 genetic polymorphisms and anti-tuberculosis-drug-induced liver injury: a correlation study. Frontiers in pharmacology 2023 9 14 1171353. Fang Cheng, Xian-Gao Jiang, Shi-Lin Zheng, Te Wu, Qiang Zhang, Xin-Chun Ye, Saiduo Liu, Ji-Chan S |
| Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohort. medRxiv : the preprint server for health sciences 2023 9 . Gustavo Amorim, James Jaworski, Marcelo Cordeiro-Santos, Afrânio L Kritski, Marina C Figueiredo, Megan Turner, Bruno B Andrade, Digna R Velez Edwards, Adalberto R Santos, Valeria C Rolla, Timothy R Sterling, David W Haas, |
| Correlation of N-acetyltransferase 2 genotype and acetylation status with plasma isoniazid concentration and its metabolic ratio in ethiopian tuberculosis patients. Scientific reports 2023 7 13 (1): 11438. Tesemma Sileshi, Nigus Fikrie Telele, Victoria Burkley, Eyasu Makonnen, Eleni Aklil |
| Pharmacogenetic interactions of efavirenz or rifampin and isoniazid with levonorgestrel emergency contraception during treatment of HIV or tuberculosis. Pharmacogenetics and genomics 2023 6 . Nana Agyemang, Kimberly K Scarsi, Paxton Baker, Laura M Smeaton, Anthony T Podany, Maxine Olefsky, Elizabeth Woolley, Elizabeth Barr, Michelle Pham, Sajeeda Mawlana, Khuanchai Supparatpinyo, Sivaporn Gatechompol, Emilia M Jalil, Luis Gadama, Sharlaa Badal-Faesen, Marije Van Schalkwyk, Cecelia Kayama, Pablo F Belaunzaran-Zamudio, Catherine Godfrey, Susan E Cohn, Rosie Mngqibisa, David W Haas, |
| Parametric population pharmacokinetics of isoniazid: a systematic review. Expert review of clinical pharmacology 2023 3 1-23. Li Jinmeng, Cai Xinjun, Chen Yueting, Wang Chenyu, Jiao Zhe |
| Relevance of NAT2 genotype and clinical factors to risk for antituberculosis drug-induced liver injury. Pharmacogenomics 2023 12 . Fang Cheng, Chao-Chao Qiu, Xian-Gao Jiang, Te Wu, Qiang Zhang, Xin Chen, Shi-Lin Zheng, Sai-Duo Liu, Xin-Chun Ye, Ji-Chan S |
| Risk adjustment model for tuberculosis compared to non-tuberculosis mycobacterium or latent tuberculosis infection: Center for Personalized Precision Medicine of Tuberculosis (cPMTb) cohort database. BMC pulmonary medicine 2023 11 23 (1): 471. Woo Jung Seo, Hyeon-Kyoung Koo, Ji Yeon Kang, Jieun Kang, So Hee Park, Hyung Koo Kang, Hye Kyeong Park, Sung-Soon Lee, Sangbong Choi, Tae Won Jang, Kyeong-Cheol Shin, Jee Youn Oh, Joon Young Choi, Jinsoo Min, Young-Kyung Choi, Jae-Gook Shin, Yong-Soon C |
| Association of Cytochrome P450 2E1 and N-Acetyltransferase 2 Genotypes with Serum Isoniazid Level and Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Cross-Sectional Study. Iranian journal of medical sciences 2023 10 48 (5): 474-483. Nasir Pourmohamadi, Mihan Pour Abdollah Toutkaboni, Nasim Hayati Roodbari, Payam Tabarsi, Shadi Baniasa |
| Differential distribution of NAT2 polymorphisms and NAT2 acetylator phenotypes among indigenous populations of the Brazilian Amazon. Pharmacogenetics and genomics 2024 9 . Jamila A Perini, Paulo C Basta, Jessica V Cardoso, Anna Beatriz R Elias, Guilherme Suarez-Kur |
| Determination of NAT2 Genotypes in a Cohort of Patients with Suspected TB in the State of Rio de Janeiro. Pharmaceutics 2024 7 16 (7): . Cecília Alvim Dutra, Raquel Lima de Figueiredo Teixeira, Márcia Quinhones Pires Lopes, Victória de Moraes Silva, Philip Noel Suffys, Ricardo de Souza Carvalho, Adriana Rezende Moreira, Adalberto Rezende Santos, Afrânio Lineu Krits |
| Pharmacogenetic Study of Drugs Affecting Mycobacterium tuberculosis. International journal of mycobacteriology 2024 6 13 (2): 206-212. Samira Shabani, Poopak Farnia, Jalaledin Ghanavi, Ali Akbar Velayati, Parissa Farn |
| Effect of NAT2, GSTM1 and CYP2E1 genetic polymorphisms on plasma concentration of isoniazid and its metabolites in patients with tuberculosis, and the assessment of exposure-response relationships. Frontiers in pharmacology 2024 4 15 1332752. Viktorija Ulanova, Agnija Kivrane, Anda Viksna, Leonora Pahirko, Lauma Freimane, Darja Sadovska, Iveta Ozere, Andra Cirule, Eduards Sevostjanovs, Solveiga Grinberga, Dace Bandere, Renate Ran |
| Pharmacogenetic variability of tuberculosis biomarkers in native and mestizo Peruvian populations. Pharmacology research & perspectives 2024 4 12 (3): e1179. Luis Jaramillo-Valverde, Kelly S Levano, David D Tarazona, Silvia Capristano, Cesar Sanchez, Julio A Poterico, Eduardo Tarazona-Santos, Heinner Gu |
| Variants in the N-acetyltranferase 2 gene, acetylator phenotypes and their association with tuberculosis: Findings in Peruvian patients. Journal of clinical tuberculosis and other mycobacterial diseases 2024 11 37 100485. Rodrigo Sánchez, Oscar Acosta, Lina Laymito, Teodoro Oscanoa, María Guevara-Fujita, Saul Moscol, Daisy Obispo, Doris Huerta, Ricardo Fuji |
| Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohort. Pharmacogenetics and genomics 2024 10 . Gustavo Amorim, James Jaworski, Jing Yang, Marcelo Cordeiro-Santos, Afrânio L Kritski, Marina C Figueiredo, Megan Turner, Bruno B Andrade, Digna R Velez Edwards, Adalberto R Santos, Valeria C Rolla, Timothy R Sterling, David W Haas, |
| Towards pharmacogenomics-guided tuberculosis (TB) therapy: N-acetyltransferase-2 genotypes among TB-infected Kenyans of mixed ethnicity. BMC medical genomics 2024 1 17 (1): 14. Lilian N Njagi, Jared O Mecha, Marianne W Mureithi, Leon E Otieno, Videlis Ndu |
| Influence of N-acetyltransferase 2 polymorphisms and clinical variables on liver function profile of tuberculosis patients. Expert review of clinical pharmacology 2024 1 1-12. Levin Thomas, Arun Prasath Raju, S Chaithra, Shrivathsa Kulavalli, Muralidhar Varma, Chidananda Sanju Sv, Mithu Baneerjee, Kavitha Saravu, Surulivelrajan Mallayasamy, Mahadev R |
- Page last reviewed:Feb 1, 2024
- Content source: